Boston Sci, Vodafone partner on mobile health monitoring

Vodafone Global Enterprise and Boston Scientific ($BSX) are teaming up to develop mobile health monitoring solutions that will give doctors real-time information about patients' cardiac health and certain vital signs remotely. Release

Suggested Articles

The FDA has authorized its first COVID-19 antibody test for use in doctors' offices, urgent care centers and emergency rooms.

The clinical testing giant LabCorp will now begin rolling out a blood test for lung cancer developed by Resolution Bioscience.

Cognoa aims to equip pediatricians with an AI-powered app that can spot the signs of autism, allowing them to diagnose in the doctor's office.